NanoSyrinx
Life Sciences • East of England • Early Stage
NanoSyrinx is a synthetic biology company, developing 'nanosyringes' as a novel platform technology for the targeted intracellular delivery of biological molecules.
Company
information
Investment date
August 2024
Head office
Cambridge
CEO
Dr. Joe Healey